Showing 42,701 - 42,720 results of 44,452 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((nn decrease) OR (mean decrease)) ))', query time: 1.30s Refine Results
  1. 42701

    Table_1_TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.docx by Andrew J. McNair (9093310)

    Published 2023
    “…SMAD2 antagonism by siRNA and the SMAD7 agonist asiaticoside decreased detection of pSMAD by at least 50%, significantly decreased expression of the aVIC gene markers ACTA2, TAGLN, and MYH10, and pαSMA, pAKT2, and pERK1, but had no effect on pS6K, pERK2, or pVIM expression in aVICs. …”
  2. 42702

    Image_3_TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.TIF by Andrew J. McNair (9093310)

    Published 2023
    “…SMAD2 antagonism by siRNA and the SMAD7 agonist asiaticoside decreased detection of pSMAD by at least 50%, significantly decreased expression of the aVIC gene markers ACTA2, TAGLN, and MYH10, and pαSMA, pAKT2, and pERK1, but had no effect on pS6K, pERK2, or pVIM expression in aVICs. …”
  3. 42703

    Data_Sheet_2_TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.docx by Andrew J. McNair (9093310)

    Published 2023
    “…SMAD2 antagonism by siRNA and the SMAD7 agonist asiaticoside decreased detection of pSMAD by at least 50%, significantly decreased expression of the aVIC gene markers ACTA2, TAGLN, and MYH10, and pαSMA, pAKT2, and pERK1, but had no effect on pS6K, pERK2, or pVIM expression in aVICs. …”
  4. 42704

    Image_1_TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.TIF by Andrew J. McNair (9093310)

    Published 2023
    “…SMAD2 antagonism by siRNA and the SMAD7 agonist asiaticoside decreased detection of pSMAD by at least 50%, significantly decreased expression of the aVIC gene markers ACTA2, TAGLN, and MYH10, and pαSMA, pAKT2, and pERK1, but had no effect on pS6K, pERK2, or pVIM expression in aVICs. …”
  5. 42705

    Data_Sheet_1_TGF-β phospho antibody array identifies altered SMAD2, PI3K/AKT/SMAD, and RAC signaling contribute to the pathogenesis of myxomatous mitral valve disease.docx by Andrew J. McNair (9093310)

    Published 2023
    “…SMAD2 antagonism by siRNA and the SMAD7 agonist asiaticoside decreased detection of pSMAD by at least 50%, significantly decreased expression of the aVIC gene markers ACTA2, TAGLN, and MYH10, and pαSMA, pAKT2, and pERK1, but had no effect on pS6K, pERK2, or pVIM expression in aVICs. …”
  6. 42706

    Table1_Associations of Long-Term Physical Activity Trajectories With All-Cause Mortality in a General Population.DOCX by Chia-Lin Lee (161345)

    Published 2023
    “…The study participants were divided into five groups according to percentiles of LTPA (<20th, 20th–<40th, 40th–<60th, 60th–<80th, ≥80th) and LTPA trajectories (low/stable, medium/stable, increasing, decreasing, and fluctuating), respectively. …”
  7. 42707
  8. 42708
  9. 42709
  10. 42710
  11. 42711
  12. 42712
  13. 42713
  14. 42714
  15. 42715
  16. 42716
  17. 42717
  18. 42718
  19. 42719

    Injection of PGE<sub>2</sub> reversed the immunosuppression induced by RNA interference (RNAi) of POX-F (A) and POX-H (B). by Jiyeong Park (626261)

    Published 2014
    “…For nodulation, 5×10<sup>5</sup> cells of <i>E. coli</i> were injected to each test larva and incubated for 8 h at 25°C. …”
  20. 42720

    SB105-A10 treatment inhibits the HIV replication of HIV-1 reference strains and isolates from HIV-1 positive pateints. by Isabella Bon (467395)

    Published 2013
    “…After two hours, several PBS washings were carried out and p24 determination was performed at day 7. Significant decreases of HIV-1 p24 amount were detected in infected samples treated with 5, 10 and 20 µg/ml of SB105-A10 with respect to the untreated controls. …”